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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To determine the clinical and cost-effectiveness of interventions (non-selective, selective or stepwise carious tissue removal, sealing of
carious lesions using sealantmaterials or preformedmetal crowns, orNRCC) to treat carious lesions conventionally considered to require
restorations (cavitated or micro-cavitated lesions, or occlusal lesions that are clinically non-cavitated but clinically/radiographically
extend into dentine) in primary or permanent teeth with vital (sensitive) pulps.
B A C K G R O U N D
Description of the condition
Dental caries is themost prevalent disease worldwide, with billions
of individuals affected by the resulting burden of pain, loss of func-
tion, impaired aesthetics and speech (Marcences 2013; Kassebaum
2015). The oral microbiota are organised on dental hard tissues
as biofilms and, under healthy conditions, these biofilms contain
limited numbers of cariogenic bacteria (including streptococci and
lactobacilli). The condition of dental caries is caused by a shift
in the composition of the oral microbiota towards increased pro-
portions of cariogenic bacteria. The mineral loss from dental hard
tissues (enamel and dentine) caused by these bacteria is usually re-
versible, withmineral supply fromdental saliva leading to reminer-
alisation. If fermentable carbohydrates (i.e. sugars) are supplied
regularly and in sufficient amount, cariogenic bacteria metabolise
the carbohydrates to produce organic acids, thus decreasing the
pHwithin the biofilms (which is why they are termed ‘acidogenic’
bacteria). As these acidogenic bacteria are also aciduric (i.e. acid-
tolerant) while most other bacteria are not, they increasingly dom-
inate the biofilm. This imbalance in the biofilm results in a dis-
crepancy in the mineral loss and gain, with a resulting net mineral
loss. If this continues over time, it can lead to development of a
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carious lesion as the symptom of the caries disease process (Marsh
2010; Takahashi 2011). Carious lesions can range from very early,
non-detectable mineral loss, that is restricted to enamel, through
to lesions that extend into dentine without any surface cavitations,
to cavitated lesions, which destroy the tooth tissue and can be vis-
ible as holes in the teeth.
Description of the intervention
Traditionally, all carious lesions have been treated by removing all
demineralised (affected) and bacterially contaminated (infected)
dentine and replacing it using restorations (based on, for example,
amalgam or composite), commonly known as a ’filling’. However,
the pathophysiology of the disease process means that carious le-
sions can be controlled by altering the factors leading to net min-
eral loss. This can be achieved by reducing carbohydrate intake;
removing or controlling the activity of the biofilm; sealing the
tooth surface from the environment; or rebalancing demineralisa-
tion and remineralisation, for example, by applying fluoride.
For carious lesions where the tooth tissue surface has become cav-
itated, these options are often no longer feasible, as the biofilm is
sheltered and cannot be easily removed or manipulated. In such
situations, invasive (restorative) options are considered to still be
required in most cases, as indicated by a recent document pub-
lished by the International Caries Consensus Conference Collab-
oration (Schwendicke 2016a). Cavitations that are clinically hard
to detect (often called microcavitations) may, upon radiographic
assessment, be found to penetrate into the dentine. These dentinal
lesions have traditionally also been considered to require a restora-
tion (Ricketts 1995), especially when the lesion has entered the
middle third of the dentine, and hence harbours large amounts of
bacteria (Bakhshandeh 2018).
There are six main strategies that we expect to be the focus of this
Cochrane Review, all considered suitable for treating cavitated/
dentine carious lesions that would historically have been regarded
as in need of a restoration. These include cavitated lesions, micro-
cavitated lesions and occlusal lesions, which appear clinically to be
non-cavitated but clearly extend intodentine seen radiographically
or clinically as grey shadowing.
• Non-selective carious tissue removal. Carious dentine and
enamel are removed, usually until only sound enamel and hard
dentine remain. The cavity is subsequently restored (this review
does not focus on the material, e.g. amalgam, composite etc. or
how this restoration is performed).
• Selective carious tissue removal. Carious dentine and
enamel are removed, usually until only sound enamel and hard
dentine remain at the cavity periphery, while centrally, dentine of
different hardnesses (soft, leathery or firm) remains. The cavity is
subsequently restored.
• Stepwise carious tissue removal. Carious dentine is removed,
as the first step, as described for selective removal to soft dentine.
The cavity is restored, for example using glass ionomer cement or
composite material, for some months. During this time, the
lesion is arrested as sealed bacteria are inactivated, dentine
remineralises, becomes hardened and dried, and tertiary dentine
is laid down close to the lesion. These processes result in a lower
risk of pulp exposure in the second step, which is traditionally
carried out as described for selective carious tissue removal to
firm dentine. Note that in older studies, the second step may
have been non-selective removal (Magnusson 1977).
• Sealing using sealant materials such as resins and glass
ionomers, placed over the carious lesion, depriving the carious
biofilm of substrate. Sealants are placed without any prior tissue
preparation, although some have advocated some preparation
(fissurotomy, enameloplasty). We will only include studies where
sealants have been placed without any carious tissue removal;
enamel may have been prepared/bevelled prior to sealing as long
as no carious dentine was removed.
• The Hall Technique. A preformed metal crown is pushed
over a carious primary molar tooth to seal in the carious lesion.
None of the carious tooth tissue is removed and, as previously
described, the biofilm cariogenic activity is reduced by being
deprived of nutrients and the lesion is arrested as the bacteria
become inactive.
• NRCC. The cavity shape is made cleansable, and the tooth
tissue is repeatedly and frequently cleansed by the patient or
carers to remove the biofilm, remineralise the lesion and prevent
it progressing.
How the intervention might work
Restoration involves the removal of demineralised carious dentine
and enamel (also termed ‘excavation’) to allow a filling, which can
be made using a variety of materials, to be placed on stable or
suitably supportive tooth tissue. The process of carious tissue re-
moval can be undertaken to various degrees. All or most carious
dentine can be removed with a ‘non-selective’ approach using a
single endpoint for removal; for example, removal until hard den-
tine in all parts of the cavity. Alternatively, carious dentine close
to the dental pulp can be left and sealed beneath the restoration,
with removal until hard dentine performed in the periphery of
the cavity. This has been termed ‘selective carious tissue removal’.
Varying endpoints are used to guide dentine removal in different
areas of the cavity (e.g. hard dentine is left peripherally, while soft
or leathery or firm dentine is left centrally). A combined step-
wise approach can also be used to treat deep carious lesions. This
approach involves selective removal to soft dentine as an initial
step; the cavity is then sealed for some months until a second
selective removal to firm dentine is performed (Innes 2016). As
only minimal numbers of bacteria are thought to survive long-
term below a restoration sealing, it is proposed that reduced den-
tine removal (resulting in increased residual dentine thickness and
avoiding pulp exposure),may improve patient benefit with limited
subsequent risk. However, it is currently unclear which of these
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strategies is most suitable for carious lesions that require restora-
tion (Bjørndal 1997; Bjørndal 2000; Paddick 2005; Schwendicke
2016b; Bjørndal 2017).
The carious process is fundamentally the same for primary and
permanent teeth. However, primary teeth are more vulnerable to
the process as they have slightly less mineral content, the enamel
and dentine layer is thinner, the dental pulps are relatively larger
and the teeth are smaller. The anatomy also affects the sequelae of
dental caries; dental infection tends to manifest more quickly in
primary teeth. This is because the communications between the
tooth and bone, where developing infection can escape from the
confine of the tooth, tend to be at the top of the roots in primary
teeth rather than the base of the roots as in permanent teeth. These
differences mean that primary teeth tend to require relatively less
disease process to experience pain and infection. There is also some
evidence that the biofilm in primary teeth may show differences;
for example, in early childhood caries, concurrent candida infec-
tion is often seen (Xiao 2016).
It has also been shown that, in some cases, no removal of carious
tissue is needed at all; instead, carious lesions can either be sealed
or otherwise controlled (Mertz-Fairhurst 1998). Sealing places a
barrier on top of the tooth surface, thereby protecting it from
any further mineral loss, and isolating sealed bacteria from dietary
carbohydrates, thereby inactivating them (Oong 2008). Various
sealant materials are used, including resin-based and glass ionomer
products. However, as these materials can be damaged by wear
and tear from chewing, sealing cavitated carious lesions with them
is not usually recommended currently (Schwendicke 2016a). In-
stead, in primary teeth, sealing can be achieved by using preformed
stainless steel crowns. This approach, the Hall Technique, has no
need for local anaesthesia, tooth preparation or carious tissue re-
moval. It is not currently clear whether sealing carious tooth tissue
using sealants (primary and permanent teeth) or the Hall Tech-
nique (primary teeth) results in good outcomes for teeth that have
traditionally been considered required carious tissue removal and
restoration (Innes 2011; Santamaría 2017).
Based on the outlined caries pathogenesis, there have been in-
vestigations into whether it might be enough to simply control
biofilm activity in cavitated carious lesions by repeated and fre-
quent removal of the biofilm through toothbrushing, using fluo-
ride to remineralise, or using antimicrobials/remineralising agents
such as silver diamine fluoride. However, this may not always be
possible or work well where the biofilm is sheltered. Based on this
idea, another intervention called Non-Restorative Cavity Control
(NRCC) aims to remove overhanging enamel from the cavity to
allow easy access to the biofilm/lesion for cleansing and removal.
The lesion can then be controlled by toothbrushing using fluo-
ridated products, provided the patient or their carers successfully
adopt and carry out this behaviour. With varying results, NRCC
has, so far, also been suggested for primary teeth and root surface
caries only; however, it might be suitable for other carious lesions
(Gruythuysen 2010; Santamaria 2014; Hansen 2017).
Why it is important to do this review
Millions of people have carious lesions treated every day; over-
treatment would carry a significant burden. Dentists worldwide
are faced daily with decisions about how best to treat carious le-
sions that were conventionally considered to be in need of restora-
tion: when and how to remove carious tissue, how much tissue
to remove, and even whether carious tissue should be removed
at all. This creates large treatment variation among clinicians
(Schwendicke 2016c; Innes 2017), which is not the best standard-
of-care for the patient. A previous Cochrane Review evaluated op-
erative interventions for managing carious lesions (Ricketts 2013);
a number of studies have been published since that review was
undertaken and methods for synthesising relevant data have ad-
vanced. Given the prevalence of the disease, its lifelong sequelae,
and the high direct and indirect costs generated (Schwendicke
2013; Schwendicke 2014; Listl 2015; Schwendicke 2015), there
is a great need to evaluate which currently available interventions
are most suitable for managing cavitated/dentine carious lesions.
O B J E C T I V E S
To determine the clinical and cost-effectiveness of interventions
(non-selective, selective or stepwise carious tissue removal, seal-
ing of carious lesions using sealant materials or preformed metal
crowns, or NRCC) to treat carious lesions conventionally consid-
ered to require restorations (cavitated or micro-cavitated lesions,
or occlusal lesions that are clinically non-cavitated but clinically/
radiographically extend into dentine) in primary or permanent
teeth with vital (sensitive) pulps.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) that compare any of the in-
terventions. We will include studies that have been randomised by
individual or by cluster. Split-mouth studies will also be eligible for
inclusion. We will exclude cross-over trials from this review as the
condition, dental caries, cannot return to baseline level following
the initial intervention.
We will include studies that compare the interventions described
for carious lesions with each other, placebo, or no treatment. If
multiple records of the same study are available, we will extract
data from all time points although we will consider outcome data
from the last follow-up for use to allow rates of outcome events to
be pooled.
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Types of participants
Participants with permanent or primary teeth, and vital pulps (i.e.
not diagnosed as having irreversible pulpitis or pulp necrosis), and
carious lesions conventionally considered to be in need of a restora-
tion, i.e. cavitated lesions on x, y and z surfaces or, on occlusal
surfaces, non-cavitated ormicro-cavitated but radiographically ex-
tending into dentine.
We have used the description “carious lesions considered to be in
need of a restoration” as we expect some, especially older, stud-
ies will not report on lesion depths or the state of the tooth sur-
face integrity, but may state that lesions required restoration. This
pragmatic approach means that although these studies may not
directly inform clinical practice recommendations, inclusion of
their data will contribute to the planned analysis. However, we
will conduct a sensitivity analysis excluding the studies which do
not fully report lesion depth or tooth surface integrity.
Types of interventions
Interventions include any comparison of conventional (non-selec-
tive), selective or stepwise carious tissue removal, sealing of cari-
ous lesions using sealant materials or preformed metal crowns, or
NRCC. We will also include ’no treatment’ interventions. Note
that not all interventions will have been applied in all situations
where restorations might have been considered the traditional
‘standard’. We acknowledge that indications for each procedure
differ depending on their presentation such as dentition (primary/
permanent), lesion depth (shallow/ moderate versus deep lesions),
clinical surface integrity (non-cavitated occlusal versus clearly and
extensive cavitated proximal-occlusal) or surface extent (one-, two-
or three-surfaced lesions) as well as surface location (occlusal,
smooth surface, proximal, root surface). For this reason it’s im-
portant to know what the pair-wise/network comparisons might
look like as the different indications increase the risk of NMA
not being appropriate/feasible, and even influences the pair-wise
comparisons that should be made.
Thus, we plan to evaluate interventions according lesion depth,
surface integrity, surface extent and location, conducting separate
analyses for the primary and permanent dentition. We acknowl-
edge that there could be studies that combine primary and perma-
nent teeth but we will endeavour to obtain data for each dentition
separately. We expect lesion depths to be heterogeneous in the
ways they are measured and recorded (clinically, radiographically)
and reporting, which is why, at this stage, we plan to distinguish
shallow/moderate lesions from deep lesions. Shallow/moderate le-
sions are those that do not extend into the pulpal area or do not
risk exposing the pulp during carious tissue removal, as measured
subjectively, or not extending into the inner third or quarter of
dentine as shown on a radiograph. We consider deep lesions as
those close to the pulp, risking exposure, extending into inner
third or quarter of dentine.
We have tried to list all likely competing interventions and the
types of lesions, teeth and the situations around which they are
likely to be used in Table 1. We will consider each of these inter-
ventions for inclusion in the network meta-analysis (NMA) but
we will analyse those carried out in primary and permanent teeth
separately.
The review will not evaluate different filling materials.
Types of outcome measures
Primary outcomes
• Presence or absence of major complications, which is a
composite measure of any complications that result in
endodontic therapy (pulp capping, pulp therapy or root-canal
treatment etc. or extraction of the tooth). This includes signs or
symptoms of irreversible pulpal inflammation or death
(including pain) and other complications, such as pulp exposure
or restoration fracture or failure or lesion progression leading to
root-canal treatment or extraction. The study authors may
present outcomes as single outcomes, but we will combine them
as composite outcomes where appropriate. We will extract and
report individual outcomes. Where included data are not
presented as separate outcomes or are cross-tabulated, we will
contact the study authors for further information. The following
primary outcomes will therefore be included:
◦ Composite outcome of major complications
(including endodontic treatment or extraction);
◦ Endodontic treatment;
◦ Extraction of tooth.
Secondary outcomes
• Minor complications, which also is a composite measure
including, for example, restoration loss treated by re-restoration,
or partial restoration failure treated by repair (Innes 2007).
Similar to the primary outcome, these aspects of this secondary
outcome may be presented in the studies as single outcomes.
They will also be extracted and reported as single outcome items,
but will be put together as composite outcomes for the review
where appropriate.
• Subjective evaluation of the treatments by participants,
regardless of the outcome measure used.
• Efficiency (time needed for the intervention), costs or cost-
effectiveness (regardless of how effectiveness was defined; note
that we will also include cost-utility or cost-benefit as outcomes).
• Any safety issues (e.g. allergies) that are related to the
interventions.
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Search methods for identification of studies
Cochrane Oral Health’s Information Specialist will conduct sys-
tematic searches for RCTs and controlled clinical trials. Due to the
CochraneCentralised Search project to identify all clinical trials on
the database and add them to CENTRAL, we will only search re-
centmonths of the Embase database. Please see the searching page
on the Cochrane Oral Health website for more information. We
will not place any other restrictions on the language or date of
publication when searching the electronic databases.
Electronic searches
Cochrane Oral Health’s Information Specialist will search the fol-
lowing databases.
• Cochrane Oral Health’s Trials Register.
• the Cochrane Central Register of Controlled Trials
(CENTRAL) in the Cochrane Register of Studies.
• MEDLINE Ovid (from 1946 onwards).
• Embase Ovid (previous six months to date).
The subject strategies for databases will be modelled on the search
strategy designed for MEDLINE Ovid in Appendix 1. Where ap-
propriate, this will be combined with subject strategy adaptations
of the highly sensitive search strategy designed by Cochrane for
identifying RCTs and controlled clinical trials as described in the
Cochrane Handbook for Systematic Reviews of Interventions (Box
6.4.c; Lefebvre 2011).
Searching other resources
We will search the following trials registries.
• US National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov (http://clinicaltrials.gov/).
• World Health Organization International Clinical Trials
Registry Platform (apps.who.int/trialsearch).
We will check the bibliographies of included studies and any rele-
vant systematic reviews identified for further references to relevant
trials.
We will not perform a separate search for adverse effects of inter-
ventions. We will consider adverse effects described in included
studies only.
Data collection and analysis
The methodology for data collection and analysis is based on the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011a). The authors will comply with the Methodological Expec-
tations of Cochrane Intervention Reviews (MECIR) document
(Chandler 2013).
Selection of studies
At least two review authors will independently screen the titles and
abstracts of records retrieved from the search against the inclusion
criteria. We have designed the literature search to be sensitive and
include controlled clinical trials; we will filter these out early in the
selection process if they are not randomised. If either review author
finds a record potentially eligible, we will obtain and assess full
texts, again independently and in duplicate. Two review authors
will decide on inclusion by consensus, or in consultation with a
third review author. We will list all studies excluded after full-text
assessment in the ‘Characteristics of excluded studies’ table. We
will illustrate the study selection process in a PRISMA diagram.
Data extraction and management
Two review authors will independently extract the data from each
included study using a specially designed data extraction form,
which we will first pilot on a small sample of studies. All review
authors who are performing data extraction will pilot this form on
the same paper(s) and we will compare the content of the fields.
The number of papers required for training to ensure calibration
will depend on the degree of agreement. We will contact study
authors for clarification or missing outcome data where necessary
and feasible.We will resolve any disagreements through discussion
and will consult a third review author when necessary to achieve
consensus.
We will extract the following data and record it in the ‘Character-
istics of included studies’ table.
• Methods: trial design, location, number of centres,
recruitment period.
• Study details: year of publication and year or study,
inclusion/exclusion criteria, number randomised/analysed, study
setting (e.g. school, practice).
• Population: age, sex and number of participants, baseline
caries experience.
• Potentially important effect modifiers (dentition; surface
location; lesion depth; surface integrity, surface extent).
• Interventions: detailed description of the interventions,
including number of teeth treated per participant.
• Outcome data: details of the outcomes reported and the
outcome measures, including method of assessment and
timepoint(s) assessed.
• Other: funding sources, declarations/conflicts of interest.
Assessment of risk of bias in included studies
Two review authors will independently assess the risk of bias of
each included study using the Cochrane domain-based, two-part
tool as described in Chapter 8 of the Cochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011b). We will contact
study authors for clarification or missing information concerning
sequence generation where necessary and feasible. We will resolve
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any disagreements through discussion, consulting a third review
author to achieve consensus when necessary.
We will complete a ‘Risk of bias’ table for each included study. For
each domain of risk of bias, we will first describe what is reported
to have happened in the study. This will provide the rationale for
our judgement of whether that domain is at low, high or unclear
risk of bias.
We will assess the following domains.
• Sequence generation (selection bias).
• Allocation concealment (selection bias).
• Blinding of outcome assessment (detection bias).
• Incomplete outcome data (attrition bias).
• Selective outcome reporting (reporting bias).
• Other bias.
Measures of treatment effect
Relative treatment effects
We will analyse dichotomous outcomes (presence or absence of
complications) by calculating the log odds ratio (lOR), and back
transforming the pooled effect estimate to be expressed as an odds
ratio. For continuous outcomes, we will pool data with mean dif-
ference (MD), or standardised mean difference (SMD Hedges’s
adjusted g) if different measures are used to assess the same out-
come. We will present the results from the NMA and pair-wise
analyses as pooled effects for each clinically relevant comparison.
Relative treatment ranking
We will estimate the relative ranking of the different interventions
according to our primary outcome using NMA.We will use mean
ranks and the cumulative ranking curve (SUCRA) (Salanti 2011;
Chaimani 2013), based on the mean treatment effect, to obtain a
hierarchy of the competing interventions according to our primary
outcome.
Unit of analysis issues
Cluster-randomised trials
Where a participant is randomised to a single intervention, and
multiple lesions within a person are being evaluated, we will con-
sider the person to be the cluster and the lesions clustered within
an individual. Where a cluster is randomised to a single interven-
tion, for example a dental clinic, and each participant within the
dental clinic is allocated to this treatment and generates outcome
data, then the clinic will be the cluster and the participants clus-
tered within the clinic.
In split-mouth studies, one or more teeth are randomised to an
intervention and comparator trial arm.
Studies with multiple treatment groups
We will account for the correlation between the effect sizes from
multi-arm studies in theNMA.Wewill treat themulti-arm studies
as multiple independent two-arm studies in pairwise meta-analy-
ses.
Dealing with missing data
Wewill use themethods described in Section 7.7.3 of theCochrane
Handbook for Systematic Reviews of Interventions to estimate miss-
ing standard deviations. We will not use any other statistical meth-
ods or perform any further imputation to account for missing data
(Higgins 2011c).
Assessment of heterogeneity
Clinical and methodological heterogeneity within treatment
comparisons
We will assess the presence of clinical heterogeneity (according to
lesion depth, surface integrity, surface extent and location) within
each pairwise comparison by comparing the trial and study pop-
ulation characteristics across all eligible trials. We will generate
descriptive statistics for trial and study population characteristics
across all eligible trials that compare each pair of interventions.
We will assess the presence of clinical heterogeneity within each
pairwise comparison by comparing these characteristics. If a suffi-
cient number of studies are included in pairwise comparison, we
will assess clinical heterogeneity by examining the characteristics
of the studies, the similarity between the types of participants, the
interventions, and the outcomes. We will only carry out meta-
analyses where there are studies of similar comparisons that report
the same outcomes.
Measures and tests for heterogeneity
We will assess statistically the presence of heterogeneity within
each pairwise comparison using a Chi² test, where a P value < 0.1
will indicate statistically significant heterogeneity. We will quan-
tify heterogeneity using the I² statistic and its 95% confidence in-
terval (CI) that measures the percentage of variability that cannot
be attributed to random error. An I² statistic of: 0% to 40%might
not be important; 30% to 60% may represent moderate hetero-
geneity; 50% to 90%may represent substantial heterogeneity; and
75% to 100% considerable heterogeneity. This is according to
Section 9.5.2 of the Cochrane Handbook for Systematic Reviews of
Interventions (Deeks 2011).
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Transitivity across treatment comparisons
We will assess the assumption of transitivity by comparing distri-
bution of potential effect modifiers across the different pairwise
comparisons of the network. We will evaluate any clinical features
that moderate the effects of the different interventions, includ-
ing dentition, lesion location (surface affected), lesion extension
(number of surfaces involved), lesion depth (clinically or radio-
graphically measured) and surface integrity (cavitation status), to
investigate the distribution of these across studies grouped by com-
parison.
Should we consider that the assumption of transitivity has not
been met, for example, in terms of substantially imbalanced dis-
tributions of prespecified effect modifiers (see above), then we will
not conduct an overall NMA. Instead we will consider subgroup-
ing studies so that NMA might be possible. We will consider per-
forming a series of independent pairwise meta-analyses if we ob-
serve heterogeneity within but not across treatment comparisons.
Assessment of statistical heterogeneity
Assumptions when estimating heterogeneity
In standard pairwise meta-analyses, we will estimate different
heterogeneity variances for each pairwise comparison. In NMA,
where feasible, we will attempt to model non-common hetero-
geneity parameters as opposed to a common estimate for the het-
erogeneity variance across the different comparisons.
Measures and tests for heterogeneity
Wewill base our assessment of statistical heterogeneity in the entire
network on themagnitude of the heterogeneity variance parameter
(τ ²) estimated from the NMA models. We will estimate a total I²
statistic value for heterogeneity in the network (Jackson 2014).
Assessment of statistical inconsistency
We will evaluate the statistical agreement between the various
sources of evidence in a network of interventions (consistency).
Since different approachesmay lead to different conclusions about
the magnitude of inconsistency, we will use both local and global
approaches.
Local approaches for evaluating inconsistency
We will use the loop-specific method to examine the consistency
between direct and indirect data (Veroniki 2013). After calculat-
ing inconsistency estimates and comparing them with the direct
estimates we will assess whether the inconsistency factor os incom-
patible with a zero null value using a 95% CI and z-test.
Global approaches for evaluating inconsistency
To check the assumption of consistency in the entire network
we will use the ‘design-by-treatment’ interaction model (Higgins
2012). After we obtain the difference between the direct and in-
direct estimates, we will use a 95% CI and z-test to infer whether
the inconsistency factor is incompatible with a zero null value.
Assessment of reporting biases
If at least 10 studies are included in a meta-analysis, we will assess
publication bias according to the recommendations on testing for
funnel plot asymmetry (Egger 1997), as described in theCochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011a).
If we identify asymmetry, we will examine possible causes. For
the NMA, we will use a comparison-adjusted funnel plot to assess
network-wide publication bias.
Data synthesis
Methods for direct treatment comparisons
Initially, we will perform standard pairwise meta-analyses using
the random-effects model in Stata 14 where there is sufficient data
for each treatment comparison (StataCorp 2015).
Methods for indirect and mixed comparisons
We will perform NMA using a multivariate approach in Stata
14. We will use the mvmeta command (White 2015), and self-
programmed Stata routines available at www.mtm.uoi.gr.
Subgroup analysis and investigation of heterogeneity
If we observe important heterogeneity or inconsistency, or both,
we will explore possible sources. If sufficient data are available, we
will conduct a meta-regression or subgroup analysis according to
lesion depth (shallow/moderate or deep). We will also investigate
the impact of lesion location (occlusal, smooth surface, proximal,
root surface), lesion surface integrity (non-cavitated occlusal ver-
sus clearly and extensive cavitated proximal-occlusal) and surface
extent (one-, two- or three-surfaced lesions). We will analyse pri-
mary and permanent teeth separately because of their anatomical
and subsequent disease sequelae manifestation differences.
Sensitivity analysis
We will conduct a sensitivity analysis to investigate the effect of
including studies that have not clearly specified lesion depths, state
of the tooth surface integrity but state only that the lesion is “con-
sidered to be in need of a restoration”.
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Presentation of results
Using GRADEpro GDT software, we will generate ’Summary of
findings’ tables for the main comparisons and primary outcome
(major complications) as per the overall and subgroup analyses.
We will consider non-selective carious tissue removal as the refer-
ence intervention. We will assess the quality of the evidence using
GRADE criteria (GRADE 2013).
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A D D I T I O N A L T A B L E S
Table 1. Interventions
Interventions Standard prac-
tice (yes/no)
Primary/per-
manent teeth
Lesion depth
(deep/shallow)
Tooth
surface location
(occlusal/
smooth surface/
proximal/root
surface)
Tooth surface
integrity (non-
cavitated/
cavitatedl)
Surface ex-
tent (1/2/3 sur-
faced lesions)
Non-
selective carious
tissue removal
Yes Primary and per-
manent teeth
Shallow and
deep
All Cavitated All
Selec-
tive carious tis-
sue removal
Yes Primary and per-
manent teeth
Shallow and
deep
All except root
surface
Cavitated All
Step-
wise carious tis-
sue removal
Yes Primary and per-
manent teeth
Deep All except root
surface
Cavitated All
Fissure/proxi-
mal sealing
Yes Primary and per-
manent teeth
Shallow All except root
surface
Mainly non-cav-
itated
1 surface
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Table 1. Interventions (Continued)
Hall technique Yes Primary teeth Shallow and
deep
All except root
surface
Cavitated All
Non-restorative
cavity control
Yes Primary and per-
manent teeth
Shallow and
deep
All Cavitated All
A P P E N D I C E S
Appendix 1. MEDLINE Ovid search strategy
1. Dental caries/
2. (caries or carious).tw.
3. ((tooth or teeth or dentin$ or dental) adj5 (decay$ or lesion$ or cavit$)).tw.
4. or/1-3
5. Dental cavity preparation/
6. “carious tissue removal”.tw.
7. ((caries or carious or cavit$) adj5 (stepwise or excavation or excavator$)).tw.
8. ((caries or carious or cavit$) adj5 ((selective or partial or incomplete) adj2 remov$)).tw.
9. ((caries or carious or cavit$) adj5 ((minimal or minimum) adj2 invas$)).tw.
10. (dentin$ adj3 remov$).tw.
11. “Pit and fissure sealants”/
12. seal$.tw.
13. Crowns/
14. (crown$ or “Hall Technique”).tw.
15. “non-restorative cavity control”.tw.
16. or/5-15
17. 4 and 16
The above search will be combined with the Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying randomised trials in
MEDLINE: sensitivity-maximising version (2008 revision) as referenced in Chapter 6.4.11.1 and detailed in box 6.4.c of the Cochrane
Handbook for Systematic Reviews of Interventions (Lefebvre 2011).
1. randomized controlled trial.pt.
2. controlled clinical trial.pt.
3. randomized.ab.
4. placebo.ab.
5. drug therapy.fs.
6. randomly.ab.
7. trial.ab.
8. groups.ab.
9. or/1-8
10. exp animals/ not humans.sh.
11. 9 not 10
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